BIVALENT BCR-ABL TYROSINE KINASE LIGANDS, AND METHODS OF USING SAME

摘要

Described herein are compounds capable of modulating one or more biomolecules substantially simultaneously, e.g., modulating two or more binding sites on a protein, e.g., Bcr-AbI tyrosine kinase, as well as methods for the treatment of diseases related to said modulation of a protein including various cancers, and further including drug resistant cancers.